BEGIN:VCALENDAR
VERSION:2.0
PRODID:talks.ox.ac.uk
BEGIN:VEVENT
SUMMARY:Targeted Immunotherapy for Pre-Invasive High Risk Human Papillomav
 irus Disease - Lucy Dorrell (University of Oxford)
DTSTART;VALUE=DATE-TIME:20180228T120000Z
DTEND;VALUE=DATE-TIME:20180228T130000Z
UID:https://talks.ox.ac.uk/talks/id/9c87ca6b-27bc-4643-8911-1e9db1385c1e/
DESCRIPTION:High risk human papillomaviruses (hrHPV) are responsible for o
 ver 0.5 million cases of cervical cancer and 70\,000 anogenital and oropha
 ryngeal cancers annually. Invasive lesions represent the end stage of a mi
 nority of persistent infections that cause progressive dysplasia over many
  years. Licensed preventive vaccines do not prevent disease in women with 
 pre-existing hrHPV infection. I will discuss progress towards development 
 of therapeutic vaccines that harness cell-mediated immune responses to eli
 minate pre-invasive lesions and persistent infections.\nSpeakers:\nLucy Do
 rrell (University of Oxford)
LOCATION:Medawar Building (Level 30 Seminar Room)\, off South Parks Road O
 X1 3SY
TZID:Europe/London
URL:https://talks.ox.ac.uk/talks/id/9c87ca6b-27bc-4643-8911-1e9db1385c1e/
BEGIN:VALARM
ACTION:display
DESCRIPTION:Talk:Targeted Immunotherapy for Pre-Invasive High Risk Human P
 apillomavirus Disease - Lucy Dorrell (University of Oxford)
TRIGGER:-PT1H
END:VALARM
END:VEVENT
END:VCALENDAR